[ Price : $8.95]
Genentech joins AbbVie in calling on FDA to provide enhanced transparency in biosimilar labeling through a unique approach rather ...[ Price : $8.95]
Drug companies recommend some changes to a draft FDA guidance on developing drugs for acute migraine treatment.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on Forms FDA 3602 and 3602A, which will allow applicants to certify that they qualify ...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on agency meetings with tobacco manufacturers, etc. on their plans to research the reg...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on: Substances Generally Recognized as Safe: Notification Procedure 21 CFR 170.36 and...[ Price : $8.95]
Federal Register FDAs Pediatric Oncology Subcommittee will meet 11/19 to discuss potential pediatric development plans for two pro...[ Price : $8.95]
PhRMA voices support for PDUFA and changes it wants in PDUFA 6.[ Price : $8.95]
36 advocacy groups ask the Senate Finance Committee to release results of a probe into the connection between drug companies and g...